Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Operating Leases: 2020-2021

Historic Operating Leases for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $29.7 million.

  • Black Diamond Therapeutics' Operating Leases rose 241.69% to $29.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $29.7 million, marking a year-over-year increase of 241.69%. This contributed to the annual value of $7.7 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Operating Leases of $29.7 million as of Q3 2021, which was up 99.60% from $14.9 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Operating Leases ranged from a high of $29.7 million in Q3 2021 and a low of $388,000 during Q2 2020.
  • Moreover, its 2-year median value for Operating Leases was $8.7 million (2020), whereas its average is $11.0 million.
  • Data for Black Diamond Therapeutics' Operating Leases shows a peak YoY spiked of 3,731.96% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Black Diamond Therapeutics' Operating Leases stood at $7.7 million in 2020, then skyrocketed by 241.69% to $29.7 million in 2021.
  • Its Operating Leases was $29.7 million in Q3 2021, compared to $14.9 million in Q2 2021 and $15.2 million in Q1 2021.